- Published on
Dermatology - Dysplastic Melanocytic Nevus
Dysplastic nevi (DN) are distinct acquired pigmented lesions characterized by the abnormal growth of melanocytes, which can potentially develop into superficial spreading melanoma. They can appear spontaneously or as a component of a compound melanocytic nevus. These nevi are clinically different from common acquired nevi, since they are larger, have more varied colors, asymmetrical outlines, and uneven borders. They also have distinct histologic findings.
Lesions typically develop in later infancy compared to common acquired nevomelanocytic nevi (NMN), which initially manifest in late childhood, shortly before puberty. Additional lesions persistently emerge over an extended period of time. While common moles typically exhibit a similar stage of growth in a certain area of the body, such as being junctional, compound, or dermal, dysplastic nevi (DN) tend to deviate from this pattern. For instance, DN may have a combination of large and small, flat and raised, tan, and extremely dark lesions.
The diagnosis is established through the clinical identification of characteristic and unique skin lesions, which are then further validated using dermoscopy. Once a diagnosis of DN is confirmed in a family member, it is advisable to also assess siblings, children, and parents for the condition. The differential diagnosis include congenital nevomelanocytic nevi, common acquired nevomelanocytic nevi (moles), superficial spreading malignant melanoma, melanoma in situ, lentigo maligna, Spitz nevus, and pigmented basal cell carcinoma.
Dysplastic nevus (DN) should be surgically removed with precise margins. The use of laser or other physical destruction methods should be avoided since they do not allow for histopathologic verification of diagnosis. It is crucial to closely monitor patients with DN in the context of familial melanoma, and it is essential to conduct regular photographic follow-up. It is important to educate patients about the distinct characteristics of DN, malignant melanoma, and typical acquired NMN as digital dermoscopy is the most dependable method. Advise patients to abstain from sunbathing or using tanning salons and to apply sunscreens while being exposed to the outdoors.
Dysplastic nevi (DN) are distinct acquired pigmented lesions characterized by the abnormal growth of melanocytes, which can potentially develop into superficial spreading melanoma. They can appear spontaneously or as a component of a compound melanocytic nevus. These nevi are clinically different from common acquired nevi, since they are larger, have more varied colors, asymmetrical outlines, and uneven borders. They also have distinct histologic findings.
Lesions typically develop in later infancy compared to common acquired nevomelanocytic nevi (NMN), which initially manifest in late childhood, shortly before puberty. Additional lesions persistently emerge over an extended period of time. While common moles typically exhibit a similar stage of growth in a certain area of the body, such as being junctional, compound, or dermal, dysplastic nevi (DN) tend to deviate from this pattern. For instance, DN may have a combination of large and small, flat and raised, tan, and extremely dark lesions.
The diagnosis is established through the clinical identification of characteristic and unique skin lesions, which are then further validated using dermoscopy. Once a diagnosis of DN is confirmed in a family member, it is advisable to also assess siblings, children, and parents for the condition. The differential diagnosis include congenital nevomelanocytic nevi, common acquired nevomelanocytic nevi (moles), superficial spreading malignant melanoma, melanoma in situ, lentigo maligna, Spitz nevus, and pigmented basal cell carcinoma.
Dysplastic nevus (DN) should be surgically removed with precise margins. The use of laser or other physical destruction methods should be avoided since they do not allow for histopathologic verification of diagnosis. It is crucial to closely monitor patients with DN in the context of familial melanoma, and it is essential to conduct regular photographic follow-up. It is important to educate patients about the distinct characteristics of DN, malignant melanoma, and typical acquired NMN as digital dermoscopy is the most dependable method. Advise patients to abstain from sunbathing or using tanning salons and to apply sunscreens while being exposed to the outdoors.
- Published on
Dermatology - Alopecia Areata
Alopecia areata refers to the specific loss of hair in circular or oval-shaped patches without any visible skin irritation. The procedure is non-scarring and preserves the integrity of the hair follicle, allowing for potential regeneration. Alopecia areata can be linked to autoimmune disorders. The age at which symptoms first appear is often during early adulthood, however it is possible for them to manifest at any stage of life.
Alopecia is a progressive condition characterized by stable patches of hair loss that may exhibit spontaneous recovery over several months. While some patches resolve, new ones may emerge.
Patients commonly experience significant distress regarding hair loss and the possibility of ongoing, gradual baldness. There is a possibility of some redness in the area where hair loss has occurred.
Lesions characterized by the presence of "exclamation mark" hairs are observed along the edges of places where hair loss has occurred, serving as a diagnostic feature.
These are truncated hairs with wider ends at the distal end compared to the proximal end. Alopecia can manifest as either isolated patches or as a complete absence of hair on the scalp, or as a widespread loss of hair on the body (including fine vellus hair). Scalp diffuse alopecia areata causes the hair to appear thinner and can be challenging to distinguish from pattern hair loss of telogen effluvium or hair loss due to thyroid disease. During the process of hair regrowth, the newly grown hairs tend to be thin and frequently appear white or gray in color.
The diagnosis is made based on clinical examination, while laboratory tests are done to exclude the possibility of lupus, syphilis, and tinea capitis. The differential diagnosis comprises white-patch tinea capitis, trichotillomania, early scarring alopecia, pattern hair loss, and secondary syphilis (alopecia areolaris) which presents as a "moth-eaten" appearance in the beard or scalp.
The treatment focuses on reducing the inflammatory infiltrate and inhibiting the growth factors produced by inflammation. However, there is presently no medication that can completely cure the condition. Psychological assistance from the dermatologist, family, and support groups is often the crucial role in managing the patient. While topical glucocorticoids are often ineffective, intralesional glucocorticoids provide brief effectiveness, and systemic glucocorticoids can stimulate regrowth, albeit momentarily, with associated long-term dangers.
Alopecia areata refers to the specific loss of hair in circular or oval-shaped patches without any visible skin irritation. The procedure is non-scarring and preserves the integrity of the hair follicle, allowing for potential regeneration. Alopecia areata can be linked to autoimmune disorders. The age at which symptoms first appear is often during early adulthood, however it is possible for them to manifest at any stage of life.
Alopecia is a progressive condition characterized by stable patches of hair loss that may exhibit spontaneous recovery over several months. While some patches resolve, new ones may emerge.
Patients commonly experience significant distress regarding hair loss and the possibility of ongoing, gradual baldness. There is a possibility of some redness in the area where hair loss has occurred.
Lesions characterized by the presence of "exclamation mark" hairs are observed along the edges of places where hair loss has occurred, serving as a diagnostic feature.
These are truncated hairs with wider ends at the distal end compared to the proximal end. Alopecia can manifest as either isolated patches or as a complete absence of hair on the scalp, or as a widespread loss of hair on the body (including fine vellus hair). Scalp diffuse alopecia areata causes the hair to appear thinner and can be challenging to distinguish from pattern hair loss of telogen effluvium or hair loss due to thyroid disease. During the process of hair regrowth, the newly grown hairs tend to be thin and frequently appear white or gray in color.
The diagnosis is made based on clinical examination, while laboratory tests are done to exclude the possibility of lupus, syphilis, and tinea capitis. The differential diagnosis comprises white-patch tinea capitis, trichotillomania, early scarring alopecia, pattern hair loss, and secondary syphilis (alopecia areolaris) which presents as a "moth-eaten" appearance in the beard or scalp.
The treatment focuses on reducing the inflammatory infiltrate and inhibiting the growth factors produced by inflammation. However, there is presently no medication that can completely cure the condition. Psychological assistance from the dermatologist, family, and support groups is often the crucial role in managing the patient. While topical glucocorticoids are often ineffective, intralesional glucocorticoids provide brief effectiveness, and systemic glucocorticoids can stimulate regrowth, albeit momentarily, with associated long-term dangers.
- Published on
Dermatology - Rosacea
Rosacea is a prevalent condition affecting around 10% of those with fair skin. It is characterized by persistent inflammation resembling acne, along with heightened sensitivity of the small blood vessels, resulting in redness and the appearance of visible blood vessels.
The age at which symptoms first appear is typically between 30 and 50 years, with a higher prevalence among women. The progression of the condition can be divided into three stages, each characterized by specific symptoms. In Stage I, there is a persistent redness of the skin and the appearance of small dilated blood vessels. In Stage II, in addition to the redness and blood vessels, there are also the presence of small raised bumps and pus-filled pimples. Stage III is characterized by a deeper redness, more prominent blood vessels, and the development of larger bumps, pimples, and nodules. In rare cases, there may also be persistent swelling in the central part of the face. Transition between stages is not always sequential, as there might be overlapping stages, and the course may commence with Stage II.
Typically, individuals with this condition experience a previous occurrence of reddening of the skin in reaction to heat stimulation in the oral cavity (such as hot beverages), spicy cuisine, alcoholic beverages, and exposure to sunlight. Patients frequently express apprehensions with their physical appearance, which can occasionally be misconstrued as indicative of alcoholism.
Abnormalities
A distinctive flushing of the face, characterized by a red coloration, may occur, either with or without the presence of small raised bumps known as papules and papulopustules, measuring 2-3 mm in diameter. The pustules typically measure less than or equal to 1 mm and are located on the top of the papules. There is an absence of comedones.
The individual has dispersed, separate lesions with telangiectases, characterized by red facies and dusky-red papules and nodules. Long-term cases of this condition result in the nose, forehead, eyes, ears, and chin being deformed due to an excessive growth of sebaceous glands and swelling of the lymphatic vessels. The lesions are symmetrically situated on the face and, infrequently, on the neck, chest (in a V-shaped region), back, and scalp.
The diagnosis is made based on clinical examination, and the possible conditions to consider are acne, perioral dermatitis, S. aureus infection, folliculitis, seborrheic dermatitis, excessive use of topical glucocorticoids, lupus, and dermatomyositis.
Apply metronidazole gel or cream, with a concentration of 0.75% or 1%, once or twice a day. Alternatively, use sodium sulfacetamide or sulfur lotions with concentrations of 10% or 5%. Topical antibiotics, such as erythromycin gel, are not as effective as oral antibiotics like minocycline or doxycycline, taken at a dose of 50-100 mg once or twice a day, or metronidazole at a dose of 500 mg twice a day. Tetracycline, although less potent, can still be beneficial. It is recommended to take 1-1.5 grams per day in many doses until symptoms improve. Once the symptoms have cleared, the dosage can be gradually reduced to a once-daily intake of 250-500 milligrams. Following the completion of the initial treatment, a regular dosage of 50 mg of minocycline or doxycycline per day, or 50 mg every other day, or 250-500 g of tetracycline, has proven to be helpful. In individuals with refractory disease, a low-dose treatment with isotretinoin, ranging from 0.1 to 0.5 mg/kg of body weight per day taken orally, is often successful for most people. However, in certain cases, a higher dosage of 1 mg/kg may be necessary. Rhinophyma and telangiectasia associated with chronic disease exhibit favorable response to surgical intervention or laser surgery.
Rosacea is a prevalent condition affecting around 10% of those with fair skin. It is characterized by persistent inflammation resembling acne, along with heightened sensitivity of the small blood vessels, resulting in redness and the appearance of visible blood vessels.
The age at which symptoms first appear is typically between 30 and 50 years, with a higher prevalence among women. The progression of the condition can be divided into three stages, each characterized by specific symptoms. In Stage I, there is a persistent redness of the skin and the appearance of small dilated blood vessels. In Stage II, in addition to the redness and blood vessels, there are also the presence of small raised bumps and pus-filled pimples. Stage III is characterized by a deeper redness, more prominent blood vessels, and the development of larger bumps, pimples, and nodules. In rare cases, there may also be persistent swelling in the central part of the face. Transition between stages is not always sequential, as there might be overlapping stages, and the course may commence with Stage II.
Typically, individuals with this condition experience a previous occurrence of reddening of the skin in reaction to heat stimulation in the oral cavity (such as hot beverages), spicy cuisine, alcoholic beverages, and exposure to sunlight. Patients frequently express apprehensions with their physical appearance, which can occasionally be misconstrued as indicative of alcoholism.
Abnormalities
A distinctive flushing of the face, characterized by a red coloration, may occur, either with or without the presence of small raised bumps known as papules and papulopustules, measuring 2-3 mm in diameter. The pustules typically measure less than or equal to 1 mm and are located on the top of the papules. There is an absence of comedones.
The individual has dispersed, separate lesions with telangiectases, characterized by red facies and dusky-red papules and nodules. Long-term cases of this condition result in the nose, forehead, eyes, ears, and chin being deformed due to an excessive growth of sebaceous glands and swelling of the lymphatic vessels. The lesions are symmetrically situated on the face and, infrequently, on the neck, chest (in a V-shaped region), back, and scalp.
The diagnosis is made based on clinical examination, and the possible conditions to consider are acne, perioral dermatitis, S. aureus infection, folliculitis, seborrheic dermatitis, excessive use of topical glucocorticoids, lupus, and dermatomyositis.
Apply metronidazole gel or cream, with a concentration of 0.75% or 1%, once or twice a day. Alternatively, use sodium sulfacetamide or sulfur lotions with concentrations of 10% or 5%. Topical antibiotics, such as erythromycin gel, are not as effective as oral antibiotics like minocycline or doxycycline, taken at a dose of 50-100 mg once or twice a day, or metronidazole at a dose of 500 mg twice a day. Tetracycline, although less potent, can still be beneficial. It is recommended to take 1-1.5 grams per day in many doses until symptoms improve. Once the symptoms have cleared, the dosage can be gradually reduced to a once-daily intake of 250-500 milligrams. Following the completion of the initial treatment, a regular dosage of 50 mg of minocycline or doxycycline per day, or 50 mg every other day, or 250-500 g of tetracycline, has proven to be helpful. In individuals with refractory disease, a low-dose treatment with isotretinoin, ranging from 0.1 to 0.5 mg/kg of body weight per day taken orally, is often successful for most people. However, in certain cases, a higher dosage of 1 mg/kg may be necessary. Rhinophyma and telangiectasia associated with chronic disease exhibit favorable response to surgical intervention or laser surgery.
- Published on
Dermatology - Keloids
Keloids and hypertrophic scars are excessive fibrous structures that form following a skin injury.
Keloids have protrusions that extend beyond the location of the initial damage, frequently resembling claw-like formations, whereas hypertrophic scars are limited to the original site of injury. Keloids can be aesthetically displeasing and present a significant challenge for patients when they are large and located on the ear, face, or near a joint. Keloids typically manifest in individuals during their third decade of life, however they can develop at any stage of adulthood. They exhibit a higher prevalence among those with darker skin tones and those with blood type A.
Keloids often do not cause any symptoms, however they may become itchy or unpleasant upon contact.
The lesions range from little papules to nodules to big tuberous lesions. Typically, they have a skin-colored appearance, however they can also be vivid red or bluish. They are characterized by their firm to hard texture and smooth surface. Following a traumatic or surgical injury, the resulting scars can exhibit a linear shape, while others may appear oval or spherical. Lesions are predominantly located on the earlobes, shoulders, upper back, and chest. Spontaneous keloids develop spontaneously without any external injury or surgical intervention, and typically manifest on the chest.
A clinical diagnosis is sufficient and a biopsy should only be considered if there is uncertainty in the clinical assessment, as it has the potential to produce further hypertrophic scarring. The differential diagnosis comprises dermatofibroma, dermatofibrosarcoma protuberans, desmoid tumor, scar with sarcoidosis, and foreign-body granuloma.
Managing the situation is difficult because there is no treatment that is significantly effective. Monthly administration of triamcinolone via intralesional injection (at a concentration of 10-40 mg/mL) can alleviate itchiness or sensitivity of the lesion, while also reducing its size and flattening it. It is important to note that this treatment is less effective for keloids compared to hypertrophic scars. Surgically removed lesions frequently have a bigger recurrence compared to the initial lesion. Surgical excision followed by rapid radiation yields favorable outcomes. Silicone creams and gels can provide advantages in the treatment of keloids, as they are both painless and noninvasive. Individuals with a predisposition to hypertrophic scars or keloids should be cautioned against undergoing cosmetic operations like ear piercing.
Keloids and hypertrophic scars are excessive fibrous structures that form following a skin injury.
Keloids have protrusions that extend beyond the location of the initial damage, frequently resembling claw-like formations, whereas hypertrophic scars are limited to the original site of injury. Keloids can be aesthetically displeasing and present a significant challenge for patients when they are large and located on the ear, face, or near a joint. Keloids typically manifest in individuals during their third decade of life, however they can develop at any stage of adulthood. They exhibit a higher prevalence among those with darker skin tones and those with blood type A.
Keloids often do not cause any symptoms, however they may become itchy or unpleasant upon contact.
The lesions range from little papules to nodules to big tuberous lesions. Typically, they have a skin-colored appearance, however they can also be vivid red or bluish. They are characterized by their firm to hard texture and smooth surface. Following a traumatic or surgical injury, the resulting scars can exhibit a linear shape, while others may appear oval or spherical. Lesions are predominantly located on the earlobes, shoulders, upper back, and chest. Spontaneous keloids develop spontaneously without any external injury or surgical intervention, and typically manifest on the chest.
A clinical diagnosis is sufficient and a biopsy should only be considered if there is uncertainty in the clinical assessment, as it has the potential to produce further hypertrophic scarring. The differential diagnosis comprises dermatofibroma, dermatofibrosarcoma protuberans, desmoid tumor, scar with sarcoidosis, and foreign-body granuloma.
Managing the situation is difficult because there is no treatment that is significantly effective. Monthly administration of triamcinolone via intralesional injection (at a concentration of 10-40 mg/mL) can alleviate itchiness or sensitivity of the lesion, while also reducing its size and flattening it. It is important to note that this treatment is less effective for keloids compared to hypertrophic scars. Surgically removed lesions frequently have a bigger recurrence compared to the initial lesion. Surgical excision followed by rapid radiation yields favorable outcomes. Silicone creams and gels can provide advantages in the treatment of keloids, as they are both painless and noninvasive. Individuals with a predisposition to hypertrophic scars or keloids should be cautioned against undergoing cosmetic operations like ear piercing.
- Published on
Dermatology - Sebaceous Hyperplasia
Sebaceous hyperplasia frequently occurs in elderly individuals, and these growths are frequently mistaken for tiny basal cell carcinoma. The condition is also seen in individuals who have received solid organ transplants and have been treated with cyclosporine.
The papules, measuring 1-3 mm in diameter, exhibit both telangiectasia and central umbilication. These objects are easily felt when touched and become more solid when pressed from the sides. It is frequently feasible to extract a minute droplet of sebum from the depressed area of the lesion.
The diagnosis is made based on clinical examination, and it is vital to consider basal cell carcinoma as a possible alternative diagnosis. Basal cell carcinoma typically presents as a firm nodule and does not produce sebum.
Sebaceous hyperplasias can be eradicated by light electrocautery.
Sebaceous hyperplasia frequently occurs in elderly individuals, and these growths are frequently mistaken for tiny basal cell carcinoma. The condition is also seen in individuals who have received solid organ transplants and have been treated with cyclosporine.
The papules, measuring 1-3 mm in diameter, exhibit both telangiectasia and central umbilication. These objects are easily felt when touched and become more solid when pressed from the sides. It is frequently feasible to extract a minute droplet of sebum from the depressed area of the lesion.
The diagnosis is made based on clinical examination, and it is vital to consider basal cell carcinoma as a possible alternative diagnosis. Basal cell carcinoma typically presents as a firm nodule and does not produce sebum.
Sebaceous hyperplasias can be eradicated by light electrocautery.
- Published on
Dermatology - Dermatitis Herpetiformis
Dermatitis herpetiformis is a long-lasting, recurring, highly itchy skin rash that often begins between the ages of 20 and 60. Males are afflicted with the condition at a rate that is twice as high as females.
The individual experiences severe and intermittent pruritus, characterized by a sensation of burning or stinging on the skin. In rare cases, pruritus may be completely absent. Symptoms typically occur before the emergence of skin lesions within a timeframe of 8 to 12 hours. The consumption of iodides and excessive intake of gluten are contributing factors that worsen the condition. Approximately 10-20% of patients exhibit laboratory findings indicating malabsorption in the small intestine. Typically, there are no systemic signs present.
Abnormalities
The lesions are characterized by red raised spots or flat patches, small solid vesicles, sometimes containing blood, and occasionally large blisters. The lesions are organized in clusters, which is why they are called herpertiformis, and their distribution is remarkably symmetrical. Scratching leads to the formation of excoriations and crusts. Postinflammatory hyperpigmentation and hypopigmentation develop in the locations where lesions have healed
The presence of clustered papulovesicles in specific areas, along with intense itching, strongly indicates the condition. In most cases, a biopsy of the initial lesions is sufficient for diagnosis. The presence of IgA deposits in the skin surrounding the lesion, as revealed by immunofluorescence, provides the most reliable confirmation. The differential diagnosis comprises several conditions such as allergic contact dermatitis, atopic dermatitis, scabies, neurotic excoriations, papular urticaria, bullous autoimmune diseases including bullous pemphigoid, and pemphigoid gestationis.
Administering Dapsone at a daily dosage of 100-150 mg, gradually reducing it to 50-25 mg, and sometimes as low as 50 mg twice a week, leads to a rapid and significant improvement, frequently observed within a few hours. Prior to initiating sulfones, it is advisable to measure the level of glucose-6-phosphate dehydrogenase. Additionally, it is recommended to assess methemoglobin levels within the first two weeks, and closely monitor blood counts during the initial months. If dapsone is not recommended due to medical reasons, sulfapyridine can be used at a dosage of 1-1.5 g per day. It is important to consume an adequate amount of fluids and closely check the presence of casts in urine as well as renal function. Following a gluten-free diet can perhaps inhibit the disease or enable a decrease in the dosage of dapsone or sulfapyridine, however the reaction is notably sluggish.
Dermatitis herpetiformis is a long-lasting, recurring, highly itchy skin rash that often begins between the ages of 20 and 60. Males are afflicted with the condition at a rate that is twice as high as females.
The individual experiences severe and intermittent pruritus, characterized by a sensation of burning or stinging on the skin. In rare cases, pruritus may be completely absent. Symptoms typically occur before the emergence of skin lesions within a timeframe of 8 to 12 hours. The consumption of iodides and excessive intake of gluten are contributing factors that worsen the condition. Approximately 10-20% of patients exhibit laboratory findings indicating malabsorption in the small intestine. Typically, there are no systemic signs present.
Abnormalities
The lesions are characterized by red raised spots or flat patches, small solid vesicles, sometimes containing blood, and occasionally large blisters. The lesions are organized in clusters, which is why they are called herpertiformis, and their distribution is remarkably symmetrical. Scratching leads to the formation of excoriations and crusts. Postinflammatory hyperpigmentation and hypopigmentation develop in the locations where lesions have healed
The presence of clustered papulovesicles in specific areas, along with intense itching, strongly indicates the condition. In most cases, a biopsy of the initial lesions is sufficient for diagnosis. The presence of IgA deposits in the skin surrounding the lesion, as revealed by immunofluorescence, provides the most reliable confirmation. The differential diagnosis comprises several conditions such as allergic contact dermatitis, atopic dermatitis, scabies, neurotic excoriations, papular urticaria, bullous autoimmune diseases including bullous pemphigoid, and pemphigoid gestationis.
Administering Dapsone at a daily dosage of 100-150 mg, gradually reducing it to 50-25 mg, and sometimes as low as 50 mg twice a week, leads to a rapid and significant improvement, frequently observed within a few hours. Prior to initiating sulfones, it is advisable to measure the level of glucose-6-phosphate dehydrogenase. Additionally, it is recommended to assess methemoglobin levels within the first two weeks, and closely monitor blood counts during the initial months. If dapsone is not recommended due to medical reasons, sulfapyridine can be used at a dosage of 1-1.5 g per day. It is important to consume an adequate amount of fluids and closely check the presence of casts in urine as well as renal function. Following a gluten-free diet can perhaps inhibit the disease or enable a decrease in the dosage of dapsone or sulfapyridine, however the reaction is notably sluggish.
- Published on
Dermatology - Postinflammatory Hyperpigmentation
Postinflammatory hyperpigmentation is a condition that occurs in people with darker skin as a result of acne, psoriasis, lichen planus, atopic dermatitis, contact dermatitis, or any inflammatory skin disease or injury. The duration of postinflammatory hyperpigmentation might range from several weeks to many months. Drug eruptions can sometimes cause an increase in skin pigmentation, namely in the melanin, which can also be linked to conditions like lichen planus and cutaneous lupus erythematosus.
Macular plaques of hyperpigmentation are typically localized to the area where the previous inflammation occurred and often have blurred, feathery edges. Riehl melanosis, also known as melanodermatitis toxica, is a patterned and merged pigmentation of the face and neck that appears black to brown-violet in color. This condition can be caused by contact or photocontact sensitivity to certain chemicals, especially fragrances found in cosmetics.
The diagnosis is based on clinical evaluation and encompasses all types of melanocytic lesions, as well as endocrine and metabolic diseases, and melasma.
Topical application of hydroquinone expedites the process of reducing excessive pigmentation in the outer layer of the skin. Dermal hyperpigmentation can be long-lasting, and there is now no remedy available.
Postinflammatory hyperpigmentation is a condition that occurs in people with darker skin as a result of acne, psoriasis, lichen planus, atopic dermatitis, contact dermatitis, or any inflammatory skin disease or injury. The duration of postinflammatory hyperpigmentation might range from several weeks to many months. Drug eruptions can sometimes cause an increase in skin pigmentation, namely in the melanin, which can also be linked to conditions like lichen planus and cutaneous lupus erythematosus.
Macular plaques of hyperpigmentation are typically localized to the area where the previous inflammation occurred and often have blurred, feathery edges. Riehl melanosis, also known as melanodermatitis toxica, is a patterned and merged pigmentation of the face and neck that appears black to brown-violet in color. This condition can be caused by contact or photocontact sensitivity to certain chemicals, especially fragrances found in cosmetics.
The diagnosis is based on clinical evaluation and encompasses all types of melanocytic lesions, as well as endocrine and metabolic diseases, and melasma.
Topical application of hydroquinone expedites the process of reducing excessive pigmentation in the outer layer of the skin. Dermal hyperpigmentation can be long-lasting, and there is now no remedy available.
- Published on
Dermatology - Infantile Hemangioma
Infantile hemangioma, sometimes referred to as strawberry hemangioma, is the prevailing neoplasm in infancy, with a prevalence of 1-2.5%, and up to 10% among Caucasian children before reaching one year of age. Females are more frequently affected than males, at a ratio of 3 to 1.
Infantile hemangiomas typically have rapid growth during the first year and then gradually shrink through a process of involution over the following 1-5 years. Involution has significant variation and is not associated with factors such as size, location, or appearance. Typically, involution is fully accomplished by the age of 10 years.
Infantile hemangiomas are pliable growths or patches that range in color from vivid red to dark purple and can be compressed. They typically measure between 1 and 8 centimeters in diameter. During the process of involution, a central area that transitions from white to gray becomes visible, and there is a possibility of ulceration. The lesions often occur as a single growth and can be found either in a specific area or spread throughout a larger territory. The most common locations for these growths are the head and neck, accounting for 50% of cases, followed by the trunk at 25%. However, lesions can also appear on the extremities and oral mucosa.
The diagnosis relies on clinical and MRI data indicating sluggish blood flow across the lesion.
The presence of GLUT-1 immunoreactivity effectively excludes the possibility of a vascular abnormality.
The majority of hemangiomas naturally regress without any lasting alteration to the skin, making a nonintervention approach the most effective and aesthetically pleasing method for managing most lesions. Treatment is necessary for around 25% of lesions that cause obstruction in important structures such as the eyes, hearing, or larynx, or that result in ulceration. Administering systemic medication is a challenging task that necessitates a high level of skill and proficiency.
Treatment options for this condition including surgical and medicinal procedures such as continuous wave or pulsed dye laser, cryosurgery, intralesional and systemic high-dose glucocorticoids, interferon α (IFN-α), and propanolol.
Infantile hemangioma, sometimes referred to as strawberry hemangioma, is the prevailing neoplasm in infancy, with a prevalence of 1-2.5%, and up to 10% among Caucasian children before reaching one year of age. Females are more frequently affected than males, at a ratio of 3 to 1.
Infantile hemangiomas typically have rapid growth during the first year and then gradually shrink through a process of involution over the following 1-5 years. Involution has significant variation and is not associated with factors such as size, location, or appearance. Typically, involution is fully accomplished by the age of 10 years.
Infantile hemangiomas are pliable growths or patches that range in color from vivid red to dark purple and can be compressed. They typically measure between 1 and 8 centimeters in diameter. During the process of involution, a central area that transitions from white to gray becomes visible, and there is a possibility of ulceration. The lesions often occur as a single growth and can be found either in a specific area or spread throughout a larger territory. The most common locations for these growths are the head and neck, accounting for 50% of cases, followed by the trunk at 25%. However, lesions can also appear on the extremities and oral mucosa.
The diagnosis relies on clinical and MRI data indicating sluggish blood flow across the lesion.
The presence of GLUT-1 immunoreactivity effectively excludes the possibility of a vascular abnormality.
The majority of hemangiomas naturally regress without any lasting alteration to the skin, making a nonintervention approach the most effective and aesthetically pleasing method for managing most lesions. Treatment is necessary for around 25% of lesions that cause obstruction in important structures such as the eyes, hearing, or larynx, or that result in ulceration. Administering systemic medication is a challenging task that necessitates a high level of skill and proficiency.
Treatment options for this condition including surgical and medicinal procedures such as continuous wave or pulsed dye laser, cryosurgery, intralesional and systemic high-dose glucocorticoids, interferon α (IFN-α), and propanolol.
- Published on
Dermatology - Oropharyngeal Candidiasis
Oral cavity infection with Candida spp. is caused by slight changes in host variables such as antibiotic medication, glucocorticoid therapy, age (infants, elderly), and weakened host defenses.
Oropharyngeal candidiasis frequently lacks symptoms, although individuals may have a sensation of burning or pain when consuming spicy or acidic foods, as well as a reduced ability to taste. Orodynophagia is present.
Thrush refers to the presence of colonies of Candida, which appear as white cottage cheese-like flecks on any mucosal surface. These flecks can range in size from 1-2 mm to covering the entire mucosal surface. Using a dry gauze pad to remove anything results in a red and inflamed mucosal area. Atrophic candidiasis manifests as a tongue that is smooth, red, and has undergone atrophy. Thrush may also manifest in some areas. Candida leukoplakia refers to the existence of white plaques that are resistant to removal. Angular cheilitis refers to the presence of candida intertrigo near the corners of the lips.
The diagnosis is established through clinical examination using potassium hydroxide (KOH) microscopy. The differential diagnosis comprises several conditions, including oral hairy leukoplakia, condyloma acuminatum, geographic tongue, hairy tongue, lichen planus, bite irritation, poor nutrition, and vitamin insufficiency.
Eliminate or cease the use of any factors that may contribute to a condition, if feasible.
Local treatment
Apply either nystatin or clotrimazole cream.
Systemic therapy
Administer oral fluconazole, itraconazole, or ketoconazole. Administer amphotericin B to treat severe cases of drug-resistant illness.
Oral cavity infection with Candida spp. is caused by slight changes in host variables such as antibiotic medication, glucocorticoid therapy, age (infants, elderly), and weakened host defenses.
Oropharyngeal candidiasis frequently lacks symptoms, although individuals may have a sensation of burning or pain when consuming spicy or acidic foods, as well as a reduced ability to taste. Orodynophagia is present.
Thrush refers to the presence of colonies of Candida, which appear as white cottage cheese-like flecks on any mucosal surface. These flecks can range in size from 1-2 mm to covering the entire mucosal surface. Using a dry gauze pad to remove anything results in a red and inflamed mucosal area. Atrophic candidiasis manifests as a tongue that is smooth, red, and has undergone atrophy. Thrush may also manifest in some areas. Candida leukoplakia refers to the existence of white plaques that are resistant to removal. Angular cheilitis refers to the presence of candida intertrigo near the corners of the lips.
The diagnosis is established through clinical examination using potassium hydroxide (KOH) microscopy. The differential diagnosis comprises several conditions, including oral hairy leukoplakia, condyloma acuminatum, geographic tongue, hairy tongue, lichen planus, bite irritation, poor nutrition, and vitamin insufficiency.
Eliminate or cease the use of any factors that may contribute to a condition, if feasible.
Local treatment
Apply either nystatin or clotrimazole cream.
Systemic therapy
Administer oral fluconazole, itraconazole, or ketoconazole. Administer amphotericin B to treat severe cases of drug-resistant illness.
- Published on
Dermatology - Sepsis
Sepsis is a systemic reaction to infection that can lead to the failure of several organs.
Patients typically exhibit elevated body temperature or abnormally low body temperature, rapid breathing, and accelerated heart rate.
Abnormalities
Erythroderma is indicative of staphylococcal or streptococcal toxic shock syndrome. Typically, people who experience this condition are young and in good overall health. Pustules, especially in newborns or individuals with weakened immune systems, indicate a fungal infection, specifically caused by Candida spp.
Pustules resulting from disseminated gonococcemia are found on the extremities, usually causing pain and appearing as gray, hemorrhagic, or black. These pustules are most frequently observed in young individuals who are otherwise in good health. Pustules can also occur as a result of local introduction of bacteria, such as in the case of staphylococcal sepsis. Purpura can result from vasculitis and is often noticeable in the small capillaries of the nail fold, particularly in individuals with thrombocytopenia, which is most typically observed in patients undergoing bone marrow transplantation. Immunocompromised individuals frequently experience opportunistic fungal infections, which typically manifest as red raised skin lesions, small red or purple spots, or pus-filled bumps that develop into purple discoloration.
Purpura fulminans can also be caused by severe meningococcemia. Cellulitis is a highly concentrated inflammation in a specific area. Blood cultures seldom yield positive results, and the normal cause of infection is bacterial.
Necrotizing fasciitis may result in positive blood cultures at a later stage of the disease as a result of the spread of bacteria through the bloodstream. Ecthyma gangrenosum is characterized by the initial formation of a red papule that later develops into a necrotic bulla. This typically occurs in the area between the umbilicus and the knees. The condition is usually caused by the spread of bacteria on the skin, although other organisms have also been observed. Ecthyma gangrenosum is most commonly seen in patients with a weakened immune system, particularly those with low levels of neutrophils. It often occurs in conjunction with an underlying malignancy.
The diagnosis is determined through clinical examination. There is a possibility of increased levels of white blood cells, C-reactive protein (CRP), and procalcitonin.
The differential diagnosis comprises cutaneous infections, medication hypersensitivity reactions, cutaneous lymphoma, psoriasis, contact dermatitis, trauma, thrombocytopenic purpura, cryoglobulinemia, and stasis dermatitis.
If the patient is not already in the Intensive Care Unit (ICU), they should be admitted immediately. Additionally, administer suitable antimicrobial medications within one hour of diagnosis, either based on empirical selection or guided by the results of a culture. Reassess the selection of antimicrobial agents on a daily basis in order to limit toxicity and optimize effectiveness. The administration of activated drotrecogin has demonstrated a reduction in fatality rates in cases of severe sepsis. Administer appropriate measures to maintain organ function.
Sepsis is a systemic reaction to infection that can lead to the failure of several organs.
Patients typically exhibit elevated body temperature or abnormally low body temperature, rapid breathing, and accelerated heart rate.
Abnormalities
Erythroderma is indicative of staphylococcal or streptococcal toxic shock syndrome. Typically, people who experience this condition are young and in good overall health. Pustules, especially in newborns or individuals with weakened immune systems, indicate a fungal infection, specifically caused by Candida spp.
Pustules resulting from disseminated gonococcemia are found on the extremities, usually causing pain and appearing as gray, hemorrhagic, or black. These pustules are most frequently observed in young individuals who are otherwise in good health. Pustules can also occur as a result of local introduction of bacteria, such as in the case of staphylococcal sepsis. Purpura can result from vasculitis and is often noticeable in the small capillaries of the nail fold, particularly in individuals with thrombocytopenia, which is most typically observed in patients undergoing bone marrow transplantation. Immunocompromised individuals frequently experience opportunistic fungal infections, which typically manifest as red raised skin lesions, small red or purple spots, or pus-filled bumps that develop into purple discoloration.
Purpura fulminans can also be caused by severe meningococcemia. Cellulitis is a highly concentrated inflammation in a specific area. Blood cultures seldom yield positive results, and the normal cause of infection is bacterial.
Necrotizing fasciitis may result in positive blood cultures at a later stage of the disease as a result of the spread of bacteria through the bloodstream. Ecthyma gangrenosum is characterized by the initial formation of a red papule that later develops into a necrotic bulla. This typically occurs in the area between the umbilicus and the knees. The condition is usually caused by the spread of bacteria on the skin, although other organisms have also been observed. Ecthyma gangrenosum is most commonly seen in patients with a weakened immune system, particularly those with low levels of neutrophils. It often occurs in conjunction with an underlying malignancy.
The diagnosis is determined through clinical examination. There is a possibility of increased levels of white blood cells, C-reactive protein (CRP), and procalcitonin.
The differential diagnosis comprises cutaneous infections, medication hypersensitivity reactions, cutaneous lymphoma, psoriasis, contact dermatitis, trauma, thrombocytopenic purpura, cryoglobulinemia, and stasis dermatitis.
If the patient is not already in the Intensive Care Unit (ICU), they should be admitted immediately. Additionally, administer suitable antimicrobial medications within one hour of diagnosis, either based on empirical selection or guided by the results of a culture. Reassess the selection of antimicrobial agents on a daily basis in order to limit toxicity and optimize effectiveness. The administration of activated drotrecogin has demonstrated a reduction in fatality rates in cases of severe sepsis. Administer appropriate measures to maintain organ function.
